A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Oncology|BRCA Mutated|High Grade Serous Ovarian Cancer|BRCA Mutated Breast Cancer
Interventions: DRUG: Veliparib
Sponsor: AbbVie